Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro
M. S. Nair, M. I. Luck, Y. Huang, Y. Sabo, D. D. Ho
The paper shows that an infectious intermediate form of SARS-CoV-2 persists in vitro after protease inhibitor treatment, potentially explaining viral rebound in patients.
bioRxiv · Dec 20, 2023 · PreprintMicrobiology